HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kayo Okamura Selected Research

Endotoxins

1/2013Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-α antibodies.
1/2013Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kayo Okamura Research Topics

Disease

6Acute Kidney Injury (Acute Renal Failure)
11/2023 - 01/2013
5Pneumonia (Pneumonitis)
01/2017 - 01/2013
4Vascular Calcification
05/2020 - 10/2015
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 01/2013
3Lung Injury
01/2017 - 01/2013
3Inflammation (Inflammations)
01/2017 - 11/2013
2Albuminuria
09/2015 - 01/2013
2Sepsis (Septicemia)
11/2013 - 01/2013
2Acute Lung Injury
01/2013 - 01/2013
1Chronic Kidney Failure (Chronic Renal Failure)
11/2023
1Azotemia
01/2023
1Acute-Phase Reaction
01/2023
1Hypertension (High Blood Pressure)
12/2022
1Edema (Dropsy)
01/2020
1Ventilator-Induced Lung Injury
01/2020
1Chronic Renal Insufficiency
11/2016
1Metabolic Diseases (Metabolic Disease)
10/2015
1Kidney Diseases (Kidney Disease)
09/2015
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2013
1Atherosclerosis
09/2011
1Hyperphosphatemia
09/2011

Drug/Important Bio-Agent (IBA)

4Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2013
3Fatty Acids (Saturated Fatty Acids)IBA
05/2020 - 10/2015
3CytokinesIBA
07/2014 - 01/2013
2Stearoyl-CoA DesaturaseIBA
05/2020 - 10/2015
2EnzymesIBA
05/2020 - 10/2015
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2013
2Activating Transcription Factor 4IBA
11/2018 - 11/2016
2Phosphates (Orthophosphate)IBA
11/2016 - 09/2011
2AlbuminsIBA
09/2015 - 01/2013
2InulinFDA Link
11/2013 - 01/2013
2EndotoxinsIBA
01/2013 - 01/2013
1salicylhydroxamic acid (SHAM)IBA
12/2022
1Adenosine Triphosphate (ATP)IBA
12/2022
1LipidsIBA
05/2020
1Surface-Active Agents (Surfactants)IBA
01/2020
1Lipocalin-2IBA
01/2020
1Cyclin TIBA
11/2018
1Transcription Factor CHOPIBA
11/2018
1Interleukin-10 (Interleukin 10)IBA
01/2017
1Phosphatidic Acids (Phosphatidic Acid)IBA
10/2015
1Small Interfering RNA (siRNA)IBA
10/2015
1Proteins (Proteins, Gene)FDA Link
11/2013
1Heparin (Liquaemin)FDA LinkGeneric
11/2013
1heparanaseIBA
11/2013
1GlucuronidaseIBA
11/2013
1Heparitin Sulfate (Heparan Sulfate)IBA
11/2013
1Messenger RNA (mRNA)IBA
11/2013
1Peroxidase (Myeloperoxidase)IBA
01/2013
1RNA (Ribonucleic Acid)IBA
01/2013
1CreatinineIBA
01/2013
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2013
1AntibodiesIBA
01/2013
1Apolipoproteins E (ApoE)IBA
09/2011
1SodiumIBA
09/2011
1sodium phosphate (trisodium phosphate)FDA LinkGeneric
09/2011

Therapy/Procedure

3Artificial Respiration (Mechanical Ventilation)
01/2022 - 01/2013
2Ligation
11/2013 - 01/2013
2Punctures
11/2013 - 01/2013
1Continuous Renal Replacement Therapy
11/2023
1Resuscitation
01/2023
1Therapeutics
01/2020
1Peritoneal Dialysis
01/2017